{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:51:35Z","timestamp":1792101095932,"version":"4.4.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011264","name":"FP7 People: Marie-Curie Actions","doi-asserted-by":"publisher","award":["721975"],"award-info":[{"award-number":["721975"]}],"id":[{"id":"10.13039\/100011264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000900","name":"European Commission Joint Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000900","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Toxicology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.comtox.2021.100206","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T12:11:58Z","timestamp":1638965518000},"page":"100206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Probabilistic modelling of developmental neurotoxicity based on a simplified adverse outcome pathway network"],"prefix":"10.1016","volume":"21","author":[{"given":"Nicoleta","family":"Sp\u00eenu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.D.","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpeng","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bal-Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Campia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Enoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith C.","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liadys","family":"Mora Lagares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjana","family":"Novi\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pamies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Worth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.comtox.2021.100206_b0005","doi-asserted-by":"crossref","first-page":"A118","DOI":"10.1289\/EHP358","article-title":"Project TENDR: Targeting environmental neuro-developmental risks. The TENDR Consensus Statement","volume":"124","author":"Bennett","year":"2016","journal-title":"Environ. Health Perspect."},{"issue":"9553","key":"10.1016\/j.comtox.2021.100206_b0010","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0140-6736(06)69665-7","article-title":"Developmental neurotoxicity of industrial chemicals","volume":"368","author":"Grandjean","year":"2006","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.comtox.2021.100206_b0015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1741-4520.2012.00377.x","article-title":"Developmental neurotoxicity testing: a path forward","volume":"52","author":"Crofton","year":"2012","journal-title":"Congenit Anom (Kyoto)"},{"key":"10.1016\/j.comtox.2021.100206_b0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.taap.2018.02.008","article-title":"Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods","volume":"354","author":"Bal-Price","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.comtox.2021.100206_b0025","series-title":"Test No. 443: Extended One-Generation Reproductive Toxicity Study. OECD Guidelines for the Testing of Chemicals","author":"OECD","year":"2018"},{"key":"10.1016\/j.comtox.2021.100206_b0030","series-title":"Test No. 426: Developmental Neurotoxicity Study. OECD Guidelines for the Testing of Chemicals","author":"OECD","year":"2007"},{"key":"10.1016\/j.comtox.2021.100206_b0035","unstructured":"USEPA, Health effects guidelines OPPTS 870.6300 Developmental Neurotoxicity Study, 1998."},{"key":"10.1016\/j.comtox.2021.100206_b0040","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.reprotox.2020.08.002","article-title":"An analysis of the limitations and uncertainties of in vivo developmental neurotoxicity testing and assessment to identify the potential for alternative approaches","volume":"96","author":"Paparella","year":"2020","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.comtox.2021.100206_b0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.taap.2018.02.004","article-title":"Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes","volume":"354","author":"Fritsche","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.comtox.2021.100206_b0050","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00204-015-1464-2","article-title":"International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes","volume":"89","author":"Bal-Price","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.comtox.2021.100206_b0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/toxsci\/kfy211","article-title":"International regulatory and scientific effort for improved developmental neurotoxicity testing","volume":"167","author":"Sachana","year":"2019","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.comtox.2021.100206_b0060","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/etc.34","article-title":"Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment","volume":"29","author":"Ankley","year":"2010","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.comtox.2021.100206_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104668","article-title":"New ideas for non-animal approaches to predict repeated-dose systemic toxicity: Report from an EPAA Blue Sky Workshop","volume":"114","author":"Mahony","year":"2020","journal-title":"Regul. Toxicol. Pharm."},{"issue":"5","key":"10.1016\/j.comtox.2021.100206_b0070","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00204-020-02774-7","article-title":"Quantitative adverse outcome pathway (qAOP) models for toxicity prediction","volume":"94","author":"Sp\u00eenu","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.comtox.2021.100206_b0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12940-020-00578-x","article-title":"Assessment of developmental neurotoxicity induced by chemical mixtures using an adverse outcome pathway concept","volume":"19","author":"Pistollato","year":"2020","journal-title":"Environ. Health"},{"issue":"6","key":"10.1016\/j.comtox.2021.100206_b0080","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/etc.4125","article-title":"Adverse outcome pathway networks I: Development and applications","volume":"37","author":"Knapen","year":"2018","journal-title":"Environ. Toxicol. Chem."},{"issue":"6","key":"10.1016\/j.comtox.2021.100206_b0085","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/etc.4124","article-title":"Adverse outcome pathway networks II: network analytics","volume":"37","author":"Villeneuve","year":"2018","journal-title":"Environ. Toxicol. Chem."},{"issue":"1","key":"10.1016\/j.comtox.2021.100206_b0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.14573\/altex.1808241","article-title":"Chemical hazard prediction and hypothesis testing using quantitative adverse outcome pathways","volume":"36","author":"Perkins","year":"2019","journal-title":"ALTEX"},{"issue":"9","key":"10.1016\/j.comtox.2021.100206_b0095","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/etc.4505","article-title":"Building and applying quantitative adverse outcome pathway models for chemical hazard and risk assessment","volume":"38","author":"Perkins","year":"2019","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.comtox.2021.100206_b0100","series-title":"Bayesian data analysis","author":"Gelman","year":"2013"},{"issue":"1","key":"10.1016\/j.comtox.2021.100206_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43586-020-00001-2","article-title":"Bayesian statistics and modelling","volume":"1","author":"van de Schoot","year":"2021","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.comtox.2021.100206_b0110","series-title":"Statistical Rethinking","author":"McElreath","year":"2016"},{"issue":"10","key":"10.1016\/j.comtox.2021.100206_b0115","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1007\/s00204-019-02551-1","article-title":"Development and analysis of an adverse outcome pathway network for human neurotoxicity","volume":"93","author":"Sp\u00eenu","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.comtox.2021.100206_b0120","doi-asserted-by":"crossref","unstructured":"Paini A, et al., Towards a qAOP framework for predictive toxicology - linking data to decisions (in press), 2021.","DOI":"10.1016\/j.comtox.2021.100195"},{"key":"10.1016\/j.comtox.2021.100206_b0125","series-title":"OECD Series on Adverse Outcome Pathways, No. 5","article-title":"Adverse Outcome Pathway on chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities","author":"Sachana","year":"2016"},{"issue":"1","key":"10.1016\/j.comtox.2021.100206_b0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/toxsci\/kfx169","article-title":"From the Cover: Developmental neurotoxicants disrupt activity in cortical networks on microelectrode arrays: results of screening 86 compounds during neural network formation","volume":"160","author":"Frank","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.comtox.2021.100206_b0135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.taap.2018.04.001","article-title":"Testing for developmental neurotoxicity using a battery of in vitro assays for key cellular events in neurodevelopment","volume":"354","author":"Harrill","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.comtox.2021.100206_b0140","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.yrtph.2015.04.004","article-title":"Increasing scientific confidence in adverse outcome pathways: application of tailored Bradford-Hill considerations for evaluating weight of evidence","volume":"72","author":"Becker","year":"2015","journal-title":"Regul. Toxicol. Pharm."},{"key":"10.1016\/j.comtox.2021.100206_b0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ntt.2015.10.001","article-title":"Expanding the test set: chemicals with potential to disrupt mammalian brain development","volume":"52","author":"Mundy","year":"2015","journal-title":"Neurotoxicol. Teratol."},{"issue":"10","key":"10.1016\/j.comtox.2021.100206_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24102006","article-title":"Multiclass classifier for P-glycoprotein substrates, inhibitors, and non-active compounds","volume":"24","author":"Mora Lagares","year":"2019","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.comtox.2021.100206_b0155","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1745-7254.2005.00068.x","article-title":"Predictive model of blood-brain barrier penetration of organic compounds","volume":"26","author":"Ma","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.comtox.2021.100206_b0160","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/bioinformatics\/bty707","article-title":"admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties","volume":"35","author":"Yang","year":"2019","journal-title":"Bioinformatics"},{"issue":"8","key":"10.1016\/j.comtox.2021.100206_b0165","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41583-020-0322-2","article-title":"Neuronal regulation of the blood-brain barrier and neurovascular coupling","volume":"21","author":"Kaplan","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.comtox.2021.100206_b0170","series-title":"Collaborative Computational Technologies for Biomedical Research","first-page":"363","article-title":"Chemspider: a platform for crowdsourced collaboration to curate data derived from public compound databases","author":"Williams","year":"2011"},{"issue":"4","key":"10.1016\/j.comtox.2021.100206_b0175","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/ci500004h","article-title":"AlzPlatform: an Alzheimer's disease domain-specific chemogenomics knowledgebase for polypharmacology and target identification research","volume":"54","author":"Liu","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.comtox.2021.100206_b0180","unstructured":"PreADMET. ADME Prediction v.2.0. 25.10.2020]; Available from: <https:\/\/preadmet.bmdrc.kr\/adme-prediction\/>."},{"issue":"3","key":"10.1016\/j.comtox.2021.100206_b0185","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1198\/004017005000000661","article-title":"Multilevel (hierarchical) modeling: what it can and cannot do","volume":"48","author":"Gelman","year":"2006","journal-title":"Technometrics"},{"key":"10.1016\/j.comtox.2021.100206_b0190","doi-asserted-by":"crossref","DOI":"10.7717\/peerj-cs.55","article-title":"Probabilistic programming in Python using PyMC3","author":"Salvatier","year":"2016","journal-title":"PeerJ Comput. Sci."},{"issue":"5","key":"10.1016\/j.comtox.2021.100206_b0195","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s11222-016-9696-4","article-title":"Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC","volume":"27","author":"Vehtari","year":"2017","journal-title":"Stat. Comput."},{"issue":"1","key":"10.1016\/j.comtox.2021.100206_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1175\/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2","article-title":"Verification of Forecasts expressed in terms of probability","volume":"78","author":"Brier","year":"1950","journal-title":"Mon. Weather Rev."},{"issue":"4","key":"10.1016\/j.comtox.2021.100206_b0205","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1214\/ss\/1177011136","article-title":"Inference from iterative simulation using multiple sequences","volume":"7","author":"Gelman","year":"1992","journal-title":"Statist. Sci."},{"issue":"3","key":"10.1016\/j.comtox.2021.100206_b0210","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.tox.2010.06.007","article-title":"PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals","volume":"278","author":"Bois","year":"2010","journal-title":"Toxicology"},{"issue":"suppl 6","key":"10.1016\/j.comtox.2021.100206_b0215","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1289\/ehp.961041405","article-title":"Population toxicokinetics of benzene","volume":"104","author":"Bois","year":"1996","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.comtox.2021.100206_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.comtox.2019.02.001","article-title":"Application of three approaches for quantitative AOP development to renal toxicity","volume":"11","author":"Zgheib","year":"2019","journal-title":"Comput. Toxicol."},{"issue":"1","key":"10.1016\/j.comtox.2021.100206_b0225","doi-asserted-by":"crossref","first-page":"6625","DOI":"10.1038\/s41598-020-63465-y","article-title":"Determining organ weight toxicity with Bayesian causal models: Improving on the analysis of relative organ weights","volume":"10","author":"Lazic","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.comtox.2021.100206_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.comtox.2020.100133","article-title":"A Bayesian neural network for toxicity prediction","volume":"16","author":"Semenova","year":"2020","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.comtox.2021.100206_b0235","article-title":"Quantification of an adverse outcome pathway network by Bayesian regression and Bayesian network modeling","author":"Jannicke Moe","year":"2020","journal-title":"Integr Environ Assess Manag"},{"issue":"3","key":"10.1016\/j.comtox.2021.100206_b0240","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/risa.13423","article-title":"Predicting the probability that a chemical causes steatosis using adverse outcome pathway Bayesian networks (AOPBNs)","volume":"40","author":"Burgoon","year":"2020","journal-title":"Risk Anal."},{"issue":"12","key":"10.1016\/j.comtox.2021.100206_b0245","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s00204-015-1634-2","article-title":"Bayesian integrated testing strategy (ITS) for skin sensitization potency assessment: a decision support system for quantitative weight of evidence and adaptive testing strategy","volume":"89","author":"Jaworska","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.comtox.2021.100206_b0250","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/toxsci\/kfy278","article-title":"Screening for developmental neurotoxicity at the National Toxicology Program: the future Is here","volume":"167","author":"Behl","year":"2019","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.comtox.2021.100206_b0255","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/026119290503300313","article-title":"Guidance on good cell culture practice. a report of the second ECVAM task force on good cell culture practice","volume":"33","author":"Coecke","year":"2005","journal-title":"Altern. Lab. Anim."},{"issue":"3","key":"10.1016\/j.comtox.2021.100206_b0260","doi-asserted-by":"crossref","first-page":"353","DOI":"10.14573\/altex.1710081","article-title":"Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems","volume":"35","author":"Pamies","year":"2018","journal-title":"ALTEX"},{"issue":"1","key":"10.1016\/j.comtox.2021.100206_b0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14573\/altex.1812191","article-title":"Toward good in vitro reporting standards","volume":"36","author":"Hartung","year":"2019","journal-title":"ALTEX"},{"issue":"10","key":"10.1016\/j.comtox.2021.100206_b0270","first-page":"1938E","article-title":"Establishment of an a priori protocol for the implementation and interpretation of an in-vitro testing battery for the assessment of developmental neurotoxicity","volume":"17","author":"Masjosthusmann","year":"2020","journal-title":"EFSA Support. Publ."},{"key":"10.1016\/j.comtox.2021.100206_b0275","series-title":"Regression and other Stories","author":"Gelman","year":"2020"},{"key":"10.1016\/j.comtox.2021.100206_b0280","doi-asserted-by":"crossref","unstructured":"OECD, Users' handbook supplement to the guidance document for developing and assessing adverse outcome pathways. OECD Series on adverse outcome pathways No 1. Series on testing & assessment No. 233. (ENV\/JM\/MONO(2016)12), 2018; Available from: https:\/\/doi.org\/10.1787\/5jlv1m9d1g32-en.","DOI":"10.1787\/5jlv1m9d1g32-en"},{"key":"#cr-split#-10.1016\/j.comtox.2021.100206_b0285.1","unstructured":"OECD, Revised guidance document on developing and assessing adverse outcome pathways (ENV\/JM\/MONO(2013)6), 2017"},{"key":"#cr-split#-10.1016\/j.comtox.2021.100206_b0285.2","unstructured":"Available from: <https:\/\/www.oecd.org\/officialdocuments\/publicdisplaydocumentpdf\/?cote=env\/jm\/mono(2013)6&doclanguage=en>."},{"issue":"7748","key":"10.1016\/j.comtox.2021.100206_b0290","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41586-019-00857-9","article-title":"Scientists rise up against statistical significance","volume":"567","author":"Amrhein","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.comtox.2021.100206_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104662","article-title":"An FDA\/CDER perspective on nonclinical testing strategies: classical toxicology approaches and new approach methodologies (NAMs)","volume":"114","author":"Avila","year":"2020","journal-title":"Regul. Toxicol. Pharm."},{"issue":"3","key":"10.1016\/j.comtox.2021.100206_b0300","doi-asserted-by":"crossref","first-page":"306","DOI":"10.14573\/altex.1712081","article-title":"Recommendation on test readiness criteria for new approach methods in toxicology: exemplified for developmental neurotoxicity","volume":"35","author":"Bal-Price","year":"2018","journal-title":"ALTEX"},{"key":"10.1016\/j.comtox.2021.100206_b0305","series-title":"Validation of Alternative Methods for Toxicity Testing","first-page":"317","article-title":"Integrated approaches to testing and assessment","author":"Worth","year":"2016"},{"issue":"3271","key":"10.1016\/j.comtox.2021.100206_b0310","article-title":"The Importance of prior sensitivity analysis in Bayesian statistics: demonstrations using an interactive Shiny app","volume":"11","author":"Depaoli","year":"2020","journal-title":"Front. Psychol."},{"key":"10.1016\/j.comtox.2021.100206_b0315","doi-asserted-by":"crossref","DOI":"10.1038\/s41562-021-01177-7","article-title":"Bayesian analysis reporting guidelines","author":"Kruschke","year":"2021","journal-title":"Nat. Hum. Behav."},{"key":"#cr-split#-10.1016\/j.comtox.2021.100206_b0320.1","unstructured":"OECD, Overview of Concepts and Available Guidance related to Integrated Approaches to Testing and Assessment (IATA). Series on Testing and Assessment, No. 329. OECD Publishing, Paris. ENV\/JM\/MONO(2020)25, 2020"},{"key":"#cr-split#-10.1016\/j.comtox.2021.100206_b0320.2","unstructured":"Available from: <http:\/\/www.oecd.org\/officialdocuments\/publicdisplaydocumentpdf\/?cote=ENV\/JM\/MONO(2020)25&docLanguage=en>."}],"container-title":["Computational Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468111321000529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468111321000529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T04:45:47Z","timestamp":1762836347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468111321000529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":66,"alternative-id":["S2468111321000529"],"URL":"https:\/\/doi.org\/10.1016\/j.comtox.2021.100206","relation":{},"ISSN":["2468-1113"],"issn-type":[{"value":"2468-1113","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probabilistic modelling of developmental neurotoxicity based on a simplified adverse outcome pathway network","name":"articletitle","label":"Article Title"},{"value":"Computational Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.comtox.2021.100206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100206"}}